跳至主要内容
临床试验/NCT01102179
NCT01102179已完成不适用

Prevalence of Vitamin D Insufficiency and Deficiency in Chronic Kidney Disease Patients in Singapore

National University of Singapore1 个研究点 分布在 1 个国家目标入组 196 人开始时间: 2010年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
196
试验地点
1
主要终点
Vitamin D 25(OH)D levels

研究概览

简要总结

Vitamin D insufficiency and deficiency is common in chronic kidney disease (CKD) patients and is associated with elevated parathyroid hormone (PTH) concentration and mineral and bone disorder (MBD). There is also increasing evidence to show that these abnormalities increase cardiovascular morbidity and mortality in CKD patients. There is a need for early identification of vitamin D insufficiency/deficiency in CKD patients to prevent its long-term complications. However, the vitamin D status of CKD patients in Singapore has not been well described. The purpose of this study is to assess the vitamin D status of predialysis CKD patients in a tertiary academic teaching hospital in Singapore, and its association with parameters for MBD. Predialysis patients from the outpatient renal clinic at the National University Hospital (NUH) will be recruited into this study. Blood samples from the patients will be collected after an overnight fast to determine their serum 25(OH)D, creatinine, phosphorus, calcium, albumin and i-PTH concentrations. These parameters will be compared among patients in various stages of CKD.

研究设计

研究类型
Observational
时间视角
Cross Sectional

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female 21 years of age or older
  • CKD stage 2 to 5 (who are not on dialysis): CKD stage 2: eGFR 60-89ml/min/1.73m2, stage 3: eGFR 30-59ml/min/1.73m2, stage 4: eGFR 15-29 ml/min/1.73m2, stage 5 eGFR <15 ml/min/1.73m2)
  • Not receiving over-the-counter or prescription vitamin D therapy
  • On a stable dose of phosphate binder (if any) for at least 1 month prior to the study

排除标准

  • History of liver and chronic inflammatory diseases, primary hyperparathyroidism and malignancies
  • Use of corticosteroids, anticonvulsants or vitamin D compounds
  • Use of an investigational agent within 30 days of study entry

结局指标

主要结局

Vitamin D 25(OH)D levels

时间窗: baseline

Vitamin D levels are only measured at one time point i.e. at baseline

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验